Simavita Online Annual Report 2017

Board of Directors and Senior Management Directors Mr Michael Spooner Non-Executive Chairman Mr Spooner was appointed as Chairman of Simavita in April 2016. Mr Spooner also serves on the Board of Directors of Mesoblast. Since 2004 he has filled various roles including as Executive Chairman from the date of the ASX public listing in 2004 until 2007. He is currently the Chairman of the Audit and Risk Committee as well as a member of the Remuneration Committee. Over the past several years Mr Spooner has served on the Board of Directors in various capacities at several Australian and international biotechnology companies, including BiVacor Pty Ltd (2009-2013), Advanced Surgical Design & Manufacture Limited (2010-2011), Peplin, Inc. (2004-2009), Hawaii Biotech, Inc. (2010-2012), Hunter Immunology Limited (2007- 2008), and as Managing Director of Ventracor Limited (2001-2003). Prior to returning to Australia in 2001, he spent much of his career internationally where he served in various roles including as a partner to PA Consulting Group, a United Kingdom-based management consultancy and a Principal Partner and Director of Consulting Services with PricewaterhouseCoopers (Coopers & Lybrand) in Hong Kong. In addition, Mr Spooner has owned and operated several international companies providing services and has consulted to a number of American and Asian public companies. Dr Gary W Pace Non-Executive Director Dr Pace was appointed as Non-Executive Director of the Company in April 2016. Dr Pace has more than 40 years of experience in the development and commercialisation of advanced life sciences and related technologies, spanning biotechnology, pharmaceuticals, medical devices, and food industries. He is a serial entrepreneur and has held senior positions in small and large-scale life sciences ventures and companies in Australia, the USA and Europe. Dr Pace has contributed to the development of the biotechnology industry through honorary university appointments and industry and government committees. Dr. Pace is currently a Director of three public companies ResMed (NYSE, RMD); Pacira Pharmaceuticals Inc (NASDAQ: PCRX) and Antisense Therapeutics (ASX: ANP) as well as several private companies. Dr. Pace holds a B.Sc. (Hons I) from the University of New South Wales and a Ph.D. from the Massachusetts Institute of Technology. Also he has held visiting academic positions at the Massachusetts Institute of Technology and the University of Queensland. Dr. Pace is an elected Fellow of the Australian Academy of Technological Sciences and Engineering. Mr Warren R. Bingham Non-Executive Director Mr Bingham was appointed as a Non-Executive Director of the Company on May 21, 2015. For more than 20 years, Mr Bingham has worked extensively in the field of medical devices and technologies, with expertise in domestic and international markets, health economics, regulatory and clinical affairs and business development. In 2001, he established the Australian subsidiary of Given Imaging Ltd., a company who pioneered the Pillcam® technology. In 2004, he successfully established Pillcam capsule endoscopy on the Medicare Benefits Scheme. During his time at Given Imaging, Mr Bingham served on the global management team which drove the company’s progression from a small, privately held, research-stage company with no revenue to a multinational, publicly traded company with revenues exceeding USD$200 million. In February 2014, Covidien plc acquired Given Imaging Ltd. for approximately USD$1 billion. Mr Bingham provides consulting and advisory services to the Life Sciences and Medtech sectors and serves as Member of the Board of the ANZ Gastrointestinal International Training Association, Vice President Asia Pacific to clinical Genomics, chair for the AusMedtech National Advisory Group and AusMedtech Health economics expert Panel, strategic advisor to the Board of the Gastroenterological Nurse College of Australia, Ambassador and strategic advisor to NFP organisation Noble Endeavours, and Alumni Ambassador for the Vinnies CEO Sleepout. Mr Bingham is also a Director of Endogene Limited and HyGleaCare Inc. Mr Bingham has qualifications in Business Administration and post graduate qualifications in Management and is also a graduate member of the Australian Institute of Company Directors. Mr Michael Spooner Dr Gary W Pace Mr Warren R. Bingham Simavita Limited 2017 Annual Report 8

RkJQdWJsaXNoZXIy MjE2NDg3